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Abstract
Obesity and cigarette smoking independently constitute major preventable causes of morbidity and mortality and obesity is
known to worsen lung inflammation in asthma. Paradoxically, higher body mass index (BMI) is associated with reduced
mortality in smoking induced COPD whereas low BMI increases mortality risk. To date, no study has investigated the effect
of a dietary-induced obesity and cigarette smoke exposure on the lung inflammation and loss of skeletal muscle mass in
mice. Male BALB/c mice were exposed to 4 cigarettes/day, 6 days/week for 7 weeks, or sham handled. Mice consumed
either standard laboratory chow (3.5 kcal/g, 12% fat) or a high fat diet (HFD, 4.3 kcal/g, 32% fat). Mice exposed to cigarette
smoke for 7 weeks had significantly more inflammatory cells in the BALF (P,0.05) and the mRNA expression of pro-
inflammatory cytokines and chemokines was significantly increased (P,0.05); HFD had no effect on these parameters.
Sham- and smoke-exposed mice consuming the HFD were significantly heavier than chow fed animals (12 and 13%,
respectively; P,0.05). Conversely, chow and HFD fed mice exposed to cigarette smoke weighed 16 and 15% less,
respectively, compared to sham animals (P,0.05). The skeletal muscles (soleus, tibialis anterior and gastrocnemius) of
cigarette smoke-exposed mice weighed significantly less than sham-exposed mice (P,0.05) and the HFD had no protective
effect. For the first time we report that cigarette smoke exposure significantly decreased insulin-like growth factor-1 (IGF-1)
mRNA expression in the gastrocnemius and tibialis anterior and IGF-1 protein in the gastrocnemius (P,0.05). We have also
shown that cigarette smoke exposure reduced circulating IGF-1 levels. IL-6 mRNA expression was significantly elevated in all
three skeletal muscles of chow fed smoke-exposed mice (P,0.05). In conclusion, these findings suggest that a down-
regulation in local IGF-1 may be responsible for the loss of skeletal muscle mass following cigarette smoke exposure in mice.
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Introduction
Globally tobacco smoking and obesity are two common causes
of preventable morbidity and mortality. Tobacco smoking is the
leading preventable cause of death in adults and accounted for
more than five million deaths worldwide in 2005 [1]. Smoking is
the major cause of chronic obstructive pulmonary disease
(COPD), a progressive disease characterized by irreversible airflow
limitation and lung inflammation, which is the fourth leading
cause of death worldwide [2]. In 2008, more than 1.4 billion adults
worldwide were classified as overweight or obese [3]. Being
overweight and obese constitutes major risk factors for type 2
diabetes, cardiovascular disease and certain forms of cancer. While
obesity is a complex multifactorial disease, the dramatic increase in
prevalence most likely reflects increased consumption of energy
rich foods and decreased physical activity [3]. Obesity has been
shown to worsen systemic inflammation and disease in a number
of clinical studies and experimental models [4–7]. Paradoxically, a
higher rather than lower body mass index (BMI) is associated with
better long-term outcomes in COPD [8,9].
While the effects of tobacco smoking on the respiratory tract are
well established, systemic consequences such as cardiovascular
disease [10], atrophy of skeletal muscle fibers [11] and muscle
dysfunction [12] are becoming increasingly recognized as
contributors to morbidity. While the decline in lung health is
directly caused by tobacco smoke, the pathophysiological mech-
anisms responsible for the systemic effects remain poorly
understood. A number of population based studies have confirmed
a state of chronic low-grade systemic inflammation, including
elevated serum levels of tumor necrosis factor-a (TNF-a,
interleukin-6 (IL-6) and C-reactive protein (CRP), in smokers
[10]. Moreover, in COPD elevated circulating levels of TNF-a,
IL-6, and CRP have been associated with skeletal muscle loss and
reduced exercise capacity [13-15]. In rodents, administration of
pro-inflammatory cytokines such as IL-1b, IL-6 and TNF-a
induce a severe wasting syndrome [16,17]. The pro-inflammatory
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cytokines TNF-a and IL-6 can induce muscle wasting by
activating key mediators in the ubiquitin-proteasome pathway
[18,19]. TNF-a also inhibits skeletal muscle regenerative pathways
through the induction of oxidative stress [20] and via NFkB-
dependent inhibition of MyoD, the transcription factor essential
for regeneration of muscle [21,22].
A number of experimental models of wasting have identified the
importance of the ubiquitin-proteasome pathway [23,24]. The
muscle specific E3 ligases, muscle-specific ring finger 1 (MuRF1)
and atrogin-1 (also known as muscle atrophy Fbox protein), are
induced in a number of rodent models of skeletal muscle wasting
including cancer, diabetes, denervation and disuse [24]. Alterna-
tively, mice deficient in either atrogin-1 or MuRF1 [23] were
protected against skeletal muscle wasting. Insulin-like growth
factor 1 (IGF-1) decreases the activity of the ubiquitin-proteasome
pathway by inhibiting the transcription of atrogin-1 and MuRF1
[25]. In addition, IGF-1 promotes skeletal muscle hypertrophy by
increasing protein synthesis and satellite cell proliferation and
differentiation [26,27], thus states of low IGF-1 may promote
skeletal muscle wasting.
While current smokers tend to have a lower BMI, central or
abdominal obesity appears to be increased and this is associated
with adverse metabolic consequences [28]. Thus the weight loss
associated with tobacco smoking may be due to loss of lean mass
rather than fat. Although obesity may be protective in patients
with severe COPD [29], obesity and overweight and tobacco
smoking are associated with low grade systemic inflammation, thus
increased body weight induced by a palatable high fat diet (HFD)
may alter the skeletal muscle wasting induced by cigarette smoke
exposure in mice. To examine this we used well established models
of diet-induced obesity [30,31] and cigarette smoke exposure
[32,33] and examined parameters of lung inflammation, body
weight and skeletal muscle wasting where we have previously
documented the effect smoke exposure and HFD on the
hypothalamic appetite regulator neuropeptide Y and fat accumu-
lation [33]. We have measured a number of pro-inflammatory
cytokines (IL-1b, IL-6, TNF-a), chemokines (MCP-1, MIP-2 and
KC) and a macrophage growth factor GM-CSF as they have been
shown to be important in cigarette smoke-induced lung inflam-
mation [34]. We measured the expression of genes that induce
skeletal muscle wasting such as atrogin-1 and MuRF1. As the
anabolic hormone IGF-1 inhibits the induction of these factors
[25,35] we measured skeletal muscle gene and protein expression
as well as plasma concentration of IGF-1. Furthermore, as low
grade systemic inflammation has been implicated in skeletal
muscle wasting we measured plasma concentrations of IL-6 and
serum amyloid A (SAA; a pro-inflammatory acute phase protein
induced in the liver by circulating cytokines IL-1b, IL-6 and TNF-
a) as well as TNF-a and IL-6 gene expression and protein in
skeletal muscle.
This is the first study to examine the effect of a HFD on the lung
inflammation and skeletal muscle loss induced by cigarette smoke
exposure in mice and identifies an important role for IGF-1 in the
skeletal muscle loss induced by cigarette smoke exposure in mice.
Materials and Methods
Animals
Specific pathogen-free male BALB/c mice were obtained from
the Animal Resource Centre Pty. Ltd. (Perth, WA, Australia),
housed at 2062uC in sterile micro-isolator cages, and maintained
on a 12:12 h light/dark cycle (lights on at 06:00 h). Mice were
allowed to acclimatize to their new environment for one week,
with ad libitum access to sterile standard laboratory chow. All
procedures were approved by the Animal Experimentation Ethics
Committee of the University of Melbourne.
Treatment
After acclimatization, mice were randomly divided into four
groups (n = 8 per group) that were matched for body weight. Two
groups of animals were exposed to cigarette smoke and two groups
were sham exposed according to our published protocol [32,34].
Briefly, animals underwent whole-body exposure to the smoke of 2
filtered cigarettes (Winfield Red, 16 mg#of tar, 1.2 mg#of
nicotine and 15 mg#of CO, Philip Morris, Melbourne, Australia),
twice a day (10:30 h and 16:30 h), 6 days a week for 7 weeks inside
an 18 liter plastic chamber. Sham animals were handled
identically without cigarette smoke exposure. Animals consumed
either standard laboratory chow (chow; 3.54 kcal/g, fat 12%,
protein 22%, carbohydrate 66%) or a high-fat diet (HFD;
4.32 kcal/g, fat 32% (saturated fat 17%), protein 18%, carbohy-
drate 50%). This well characterized [30,36] HFD consists of
modified laboratory chow containing sweetened condensed milk
and lard, supplemented with highly palatable cafeteria style foods
such as meat pies, cakes, and biscuits. Thus the four groups were 1)
sham and chow fed, 2) sham and HFD fed, 3) smoke exposed and
chow fed and 4) smoke exposed and HFD fed.
Tissue Collection
After the seven week protocol mice were given an anesthetic
overdose (ketamine and xylazine, 180 and 32 mg/kg i.p.,
respectively), and blood was collected from the abdominal vena
cava and processed for plasma. Separated plasma was stored at
280uC for subsequent determination of plasma IGF-I, cytokine
and SAA concentrations. Whole lungs were perfused free of blood
via right ventricular perfusion with 10 ml of PBS, rapidly
removed, blotted and snap frozen in liquid nitrogen and stored
at 280uC for subsequent quantitative RT-PCR and protein
determination by ELISA. The gastrocnemius, soleus and tibialis
anterior hind limb skeletal muscles were weighed and snap frozen
in liquid nitrogen and stored at 280uC for subsequent analysis.
The reported weights are the average of the left and right skeletal
muscle.
Cellular Inflammatory Response
Bronchoalveolar lavage fluid (BALF) was collected as previously
described [34]. Viable cells in BALF were counted by fluorescence
microscopy and cytospins were prepared using 200 ml BALF spun
at 350 rpm for 10 min on a Cytospin 3 (Shandon, UK). Cytospin
slides were stained with DiffQuik (Dade Baxter, Australia) and 500
cells per slide were differentiated into eosinophils, neutrophils,
lymphocytes and macrophages by standard morphological criteria.
BALF was centrifuged to pellet cells and the clarified BALF stored
at 280uC.
Preparation of tissue homogenates for protein
determination
As previously described [37,38], an amount of frozen lung tissue
or gastrocnemius skeletal muscle was weighed and placed into a
tube containing T-PER tissue protein extraction reagent (Thermo
Fisher Scientific, IL, USA) and Halt Protease Inhibitor Cocktail
(1:100 dilution; Thermo Fisher Scientific). The tissues were
homogenized using the Qiagen TissueLyser (MD, USA) and
Qiagen stainless steel beads (5 mm). The homogenates were
centrifuged at 9 000 g for 10 minutes at 4uC and the supernatants
collected and frozen at 280 for subsequent analysis using ELISA.
Smoke and HFD-Induced Inflammation and Wasting
PLOS ONE | www.plosone.org 2 November 2013 | Volume 8 | Issue 11 | e80471
Total protein concentration in lung was determined using the
BCA protein assay method (Bio-Rad, CA, USA).
ELISA
The protein concentrations of GM-CSF, IL-1b, IL-6, IGF-I, KC,
MCP-1, MIP-2, SAA and TNF-a, were determined using commer-
cially available ELISA kits. R&DSystems (MN,USA) DuoSet ELISA
kits were used to measure IL-1b IGF-I, KC, TNF-a, and MIP-2
levels, and eBioscience ELISA kits (CA, USA) were used to determine
IL-6, GM-CSF and MCP-1 levels. Plasma SAA concentration was
determined using an ELISA kit from BioSource (CA, USA).
Quantitative RT-PCR
Total RNA was isolated from lung tissue and skeletal muscle
using an RNeasy kit (Qiagen, MD, USA) according to the
manufacturer’s instructions. The purified total RNA was used as a
template to generate first-strand cDNA synthesis using Super-
Script III (Invitrogen, CA, USA). Pre-optimized TaqManH gene
expression assays (Applied Biosystems, CA, USA) were used for
RT-PCR using an ABI 7900 HT Sequence Detection System
(Applied Biosystems). Gene expression was quantified in a single
multiplexing reaction, where our gene of interest (for skeletal
muscle: IGF-I, atrogin-1, MuRF1, IL-6, and TNF-a; for lung: IL-
1b, IL-6, KC, TNF-a, MCP-1, MIP-2, and GM-CSF) was
standardized to 18S rRNA as previously described [34]. For each
gene of interest an individual sample from the sham and chow fed
group was assigned as a calibrator against which all other samples
are expressed as a fold difference.
Statistical analyses
Results are expressed as mean6SE. All data were analyzed
using two-way ANOVA and when statistical significance was
achieved a post hoc Bonferroni test was used to compare between
treatment groups. All statistical analyses were performed with
Figure 1. Effect of subchronic cigarette smoke exposure and HFD on BALF cellularity. Male BALB/c mice were exposed to 4 cigarettes/day,
6 days/week for 7 weeks and the number of total cells (A), macrophages (B), neutrophils (C) and lymphocytes (D) were counted. Mice had access to
either standard laboratory chow (%) or a HFD (&) across the 7 week experimental period. Data are shown as mean6SE for n = 8 per treatment group.
Data were analysed by two-way ANOVA and when significance was achieved a post hoc Bonferroni test was performed. * P,0.05 significant post hoc
effect of smoke exposure compared to sham animals on the same diet.
doi:10.1371/journal.pone.0080471.g001
Table 1. The effect of subchronic cigarette smoke exposure
and a HFD on BALF protein levels of cytokines and
chemokines.
Sham Smoke
Chow HFD Chow HFD
IL-1b protein (pg/ml) 60610 51611 74610 61612
IL-6 protein (pg/ml) 225629 175623 164626 187629
TNF-a protein (pg/ml) 147626 132632 142624 171625
MIP-2 protein (pg/ml) 160619 148618 166620 181618
KC protein (pg/ml) 43614 2363 255639* 235631*
GM-CSF protein (pg/ml) 58618 39620 164613* 163633*
MCP-1 protein concentration in BALF was below the detection sensitivity of the
ELISA.
Results are expressed as mean6SE; n = 8 per group. Data were analysed by two-
way ANOVA and where appropriate a post hoc Bonferroni test was used.
*P,0.05 significant post hoc effect of smoke exposure compared to sham
animals on the same diet.
doi:10.1371/journal.pone.0080471.t001
Smoke and HFD-Induced Inflammation and Wasting
PLOS ONE | www.plosone.org 3 November 2013 | Volume 8 | Issue 11 | e80471
GraphPad Prism for Windows (version 4.02). In all cases,
probability values less than 0.05 (P,0.05) were considered
statistically significant.
Results
Effect of cigarette smoke exposure and HFD on BALF
cellularity
Cigarette smoke exposure (4 cigarettes/day, 6 days/week for 7
weeks) significantly increased the total, macrophage, neutrophil
and lymphocyte number in BALF (P,0.05, Figure 1A-D). The
HFD had no significant effect on BALF cellularity in either the
sham or smoke-exposed animals (Figure 1A-D).
Effect of cigarette smoke exposure and HFD on cytokine
and chemokine protein levels in BALF
Cigarette smoke exposure significantly elevated GM-CSF and
KC protein concentrations in BALF (P,0.05, Table 1). There was
no effect of the HFD or cigarette smoke exposure on IL-1b, IL-6,
TNF-a or MIP-2, protein levels in BALF. MCP-1 was not
detectable in BALF.
Effect of cigarette smoke exposure and HFD on cytokine
and chemokine gene and protein levels in lung tissue
Cigarette smoke exposure significantly elevated the mRNA
expression of IL-1b, IL-6, MCP-1, MIP-2, KC and GM-CSF in
the lung tissue of chow and HFD fed animals (Table 2, P,0.05).
While cigarette smoke exposure had a significant effect on TNF-a
mRNA expression (P= 0.02) in the lung tissue of chow and HFD
fed animals this did not reach statistical significance following post-
hoc analysis. There was no effect of the HFD or cigarette smoke
exposure on protein levels of these cytokines and chemokines in
lung tissue (data not shown). The HFD did not significantly alter
the expression of the genes examined (Table 2).
Effect of cigarette smoke exposure and HFD on body
weight, skeletal muscle weights and plasma IGF-I and
SAA concentrations
After 7 weeks of consuming the HFD, the body weight of the
sham and cigarette smoke exposed animals was significantly
increased compared to the appropriate chow fed group by 12%
and 13%, respectively (Table 2, P,0.05). Conversely, mice
exposed to cigarette smoke had significantly lower body weight
compared to the sham mice (chow fed animals by 16% and HFD
fed animals by 15%; Table 3, P,0.05).
Table 2. The effect of subchronic cigarette smoke exposure and a HFD on lung tissue mRNA expression of cytokines and
chemokines.
Sham Smoke
Chow HFD Chow HFD
IL-1b mRNA (fold D) 1.0260.06 1.0660.09 1.9860.15* 2.0860.25*
IL-6 mRNA (fold D) 1.0060.11 1.1860.16 2.3760.22* 3.0660.66*
TNF-a mRNA (fold D) 1.0060.21 0.8160.07 2.2060.58 2.0160.54
MCP-1 mRNA (fold D) 1.0060.15 0.9360.16 3.5160.62* 3.5160.50*
MIP-2 mRNA (fold D) 1.0060.12 0.7360.05 4.7460.51* 4.9460.54*
KC mRNA (fold D) 1.0560.13 0.8760.09 12.9861.29* 15.9261.56*
GM-CSF mRNA (fold D) 1.0060.10 1.0760.07 2.8760.39* 3.0760.27*
Results are expressed as mean6SE; n = 8 per group. Data were analysed by two-way ANOVA and where appropriate a post hoc Bonferroni test was used.
*P,0.05 significant post hoc effect of smoke exposure compared to sham animals on the same diet.
doi:10.1371/journal.pone.0080471.t002
Table 3. The effect of subchronic cigarette smoke exposure and a HFD on body weight, skeletal muscle weights and circulating
IGF-I and SAA protein levels.
Sham Smoke
Chow HFD Chow HFD
Body weight (g) 26.660.4 29.860.7{ 22.460.5* 25.360.4*{
Soleus skeletal muscle (mg) 7.160.1 7.860.1{ 6.460.6* 6.860.1*
Tibialis anterior skeletal muscle (mg) 51.760.9 53.161.0 46.461.5* 47.160.4*
Gastrocnemius skeletal muscle (mg) 128.861.6 132.762.5 116.163.8* 119.861.1*
Plasma IGF-I (ng/ml) 117.167.7 139.0611.4 97.766.6 103.466.1*
Plasma SAA (mg/ml) 8.260.5 8.660.4 9.160.7 9.761.3
Results are expressed as mean6SE; n = 8 per group. Data were analysed by two-way ANOVA and where appropriate a post hoc Bonferroni test was used.
*P,0.05 significant post hoc effect of smoke exposure compared to sham animals on the same diet.
{P,0.05, significant post hoc effect of the HFD compared to chow fed animals.
doi:10.1371/journal.pone.0080471.t003
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Cigarette smoke exposure significantly decreased the weights of
all three skeletal muscles examined in both dietary groups
(Table 3, P,0.05). Specifically, cigarette smoke exposure
significantly reduced the weights of the soleus, tibialis anterior
and gastrocnemius skeletal muscles by 9.2, 10.3 and 9.9%,
respectively, in the chow fed animals and by 12.6, 11.3 and 9.7%,
respectively, in the HFD fed animals. The HFD had no effect on
the tibialis anterior and gastrocnemius skeletal muscle weights for
the sham and cigarette smoke exposed animals. The HFD
significantly increased the weight of the soleus skeletal muscle of
the sham animals by 9.9% compared to those consuming chow
(P,0.05).
Cigarette smoke exposure had a significant effect on the
plasma concentration of the anabolic hormone IGF-1 and post
hoc analysis revealed a significant effect in the HFD fed animals
with smoke exposure decreasing plasma IGF-1 level by 26%
compared to sham HFD fed animals (Table 3, P,0.05). Plasma
IGF-1 level was not significantly altered by the HFD (Table 3).
In the current study, while there was an induction of
inflammatory genes in the lung following cigarette smoke
exposure systemic inflammation as measured by SAA was not
significantly altered. Specifically, both the HFD and cigarette
smoke exposure had no significant effect on plasma SAA
concentration (Table 3). Plasma concentration of IL-6 was
below the level of detection of the ELISA used.
Effect of cigarette smoke exposure and HFD on skeletal
muscle gene expression
Cigarette smoke exposure had no effect on IGF-1 mRNA
expression in the soleus skeletal muscle (Figure 2A) whereas it
had a significant effect on IGF-1 gene expression in both the
tibialis anterior and gastrocnemius muscles (Figure 2B and C,
P,0.05). Specifically, smoke exposure significantly decreased
IGF-1 mRNA expression in both the tibialis anterior and
gastrocnemius skeletal muscles of the HFD and chow fed animals
compared to sham animals of the same dietary group (P,0.05).
The HFD significantly increased IGF-1 mRNA expression in the
tibialis anterior compared to chow fed animals (Figure 2B,
P,0.05).
The mRNA expression of atrogin-1 was not altered by either
the HFD or smoke exposure in the soleus and tibialis anterior
skeletal muscles (Figure 3A and B). In the gastrocnemius muscle
cigarette smoke exposure significantly increased atrogin-1 mRNA
expression of the chow fed animals (Figure 3C, P,0.05). In
contrast, the HFD significantly attenuated this smoke-induced
increase in atrogin-1 mRNA expression in the gastrocnemius
skeletal muscle (Figure 3C, P,0.05). The mRNA expression of
MuRF-1 was significantly increased in the soleus skeletal muscle
by the HFD in sham and smoke exposed mice (Figure 3D,
P,0.05) but was not affected by either cigarette smoke exposure
or HFD in the tibialis anterior and the gastrocnemius skeletal
muscles (Figure 3E and F).
In the chow fed animals, cigarette smoke exposure significantly
increased the mRNA expression of IL-6 in the soleus, tibialis
anterior and gastrocnemius muscles (Figure 4, P,0.05) and this
smoke-induced increase in IL-6 mRNA expression was signifi-
cantly reduced by the HFD in the soleus and gastrocnemius
skeletal muscles (P,0.05). In contrast, IL-6 protein level was not
altered by cigarette smoke exposure or the HFD in the
gastrocnemius (data not shown). The smoke exposure and HFD
had no effect on TNF-a gene expression in the skeletal muscles
examined (data not shown) and TNF-a protein level in the
gastrocnemius (data not shown).
While the HFD did not alter IGF-1 protein level in the
gastrocnemius skeletal muscle (Figure 5), cigarette smoke exposure
significantly decreased IGF-1 protein level (P,0.05) in the chow
fed animals (P,0.05).
Figure 2. Effect of subchronic cigarette smoke exposure andHFD
on IGF-1 mRNA expression in skeletal muscles. Male BALB/c mice
were exposed to 4 cigarettes/day, 6 days/week for 7 weeks and the mRNA
expression of IGF-I in the soleus (A), tibialis anterior (B) and gastrocnemius
(C) skeletal muscles was measured. Mice had access to either standard
laboratory chow (%) or a HFD (&) across the 7 week experimental period.
Data are shown as mean6SE and each sample was performed in
duplicate (n=8 per treatment group). Gene expression was normalized to
18S rRNA and expressed as a fold change relative to the Sham and Chow
group. Data were analysed by two-way ANOVA and when statistical
significance was achieved a post hoc Bonferroni test was performed. *
P,0.05 significant post hoc effect of smoke exposure compared to sham
animals on the same diet. { P,0.05 significant post hoc effect of HFD
compared to chow fed animals.
doi:10.1371/journal.pone.0080471.g002
Smoke and HFD-Induced Inflammation and Wasting
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Discussion
Tobacco smoking and obesity are the two major causes of
preventable morbidity and mortality worldwide and drastically
shorten life expectancy but their interaction is poorly understood.
To our knowledge this is the first study to examine the effect of a
HFD on the lung inflammation and skeletal muscle wasting
induced by cigarette smoke exposure in mice. While the
pulmonary effects of cigarette smoke exposure have been
extensively studied in rodents, the mechanisms responsible for
skeletal muscle loss following cigarette smoke exposure remain to
be determined. There is accumulating evidence of a causal link
between obesity and respiratory diseases like asthma in children,
adolescents and adults [39]. Moreover, mice with genetic or diet-
induced obesity have innate airway hyperresponsiveness (AHR),
increased ozone-induced pulmonary inflammation, altered im-
mune responses to influenza (A/PR8/34) infection and allergen
challenge [6,7,40]. As there is accumulating evidence that diet-
induced obesity can worsen the pulmonary inflammation induced
Figure 3. The effect of subchronic cigarette smoke exposure and HFD on the mRNA expression of atrogenes in skeletal muscles.
Male BALB/c mice were exposed to 4 cigarettes/day, 6 days/week for 7 weeks and the mRNA expression of atrogin-1 (A-C) and MuRF1 (D-E) in the
soleus, tibialis anterior, and gastrocnemius skeletal muscles was determined. Mice had access to either standard laboratory chow (%) or a HFD (&)
across the 7 week experimental period. Data are shown as mean6SE and each sample was performed in duplicate (n = 8 per treatment group). Gene
expression was normalized to 18S rRNA and expressed as a fold change relative to the Sham and Chow group. Data were analysed by two-way
ANOVA and when statistical significance was achieved a post hoc Bonferroni test was performed. * P,0.05 significant post hoc effect of smoke
exposure compared to sham animals on the same diet. { P,0.05 significant post hoc effect of HFD compared to chow fed animals.
doi:10.1371/journal.pone.0080471.g003
Smoke and HFD-Induced Inflammation and Wasting
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by external noxious stimuli, we hypothesized that the HFD would
worsen the lung inflammation and skeletal muscle wasting
associated with cigarette smoke exposure in mice. In contrast we
found that the pulmonary inflammation and skeletal muscle
wasting induced by cigarette smoke exposure was in general not
altered by the HFD.
Consistent with our previous reports cigarette smoke exposure
[34,41] significantly induced gene expression of a number of
inflammatory cytokines (IL-1b and IL-6) and chemokines (MCP-1,
MIP-2, KC and GM-CSF) in lung tissue and significantly
increased KC and GM-CSF protein levels in the BALF of both
dietary groups. KC is an important neutrophil chemoattractant,
whereas GM-CSF promotes neutrophil and macrophage activa-
tion and survival. The elevation in KC and GM-CSF protein was
concordant with an induction in gene expression in lung tissue of
smoke-exposed mice regardless of diet and most likely explains the
very large increase in BALF neutrophil numbers. MIP-2 mRNA
expression, another important neutrophil chemoattractant, was
also increased in the lungs of cigarette smoke-exposed chow and
HFD fed animals. The absence of elevated protein levels for
several inflammatory cytokines up-regulated at the transcript level
most likely reflects differences in transcriptional and translational
kinetics but it was not technically feasible to add additional time
points to the current study.
Circulating cytokines IL1b, IL-6 and TNF-a are known to
promote the secretion of SAA, a pro-inflammatory acute phase
protein, from the liver. Human and rodent obesity are associated
with chronically elevated levels of SAA, which are reduced
following weight loss [42,43]. The weight gain induced by the
HFD in this study was not sufficient to alter SAA levels. Human
studies have shown that smoking is associated with increased
systemic inflammation [10] and chronic low-grade systemic
inflammation is thought to contribute to the skeletal muscle
wasting observed in COPD patients [13–15,44,45]. In the current
study, while there was an induction of inflammatory genes in the
lung following cigarette smoke exposure systemic inflammation as
measured by SAA was not significantly altered. In addition, the
level of circulating IL-6 was below the detection limit of the
ELISA. Due to a limited volume of sample we could not measure
systemic TNF-a level as an alternative marker of systemic
inflammation. However it was recently shown that circulating
TNF-a was significantly elevated in C57BL/6 mice exposed to
cigarette smoke for 6 months but this was not associated with
skeletal muscle wasting [46]. In contrast, Tang and colleagues [47]
Figure 4. The effect of subchronic cigarette smoke exposure
and HFD on IL-6 mRNA expression in skeletal muscles. Male
BALB/c mice were exposed to 4 cigarettes/day, 6 days/week for 7 weeks
and the mRNA expression of IL-6 in the soleus (A), tibialis anterior (B)
and gastrocnemius (C) skeletal muscles was determined. Mice had
access to either standard laboratory chow (%) or a HFD (&) across the
7 week experimental period. Data are shown as mean6SE and each
sample was performed in duplicate (n = 8 per treatment group). Gene
expression was normalized to 18S rRNA and expressed as a fold change
relative to the Sham and Chow group. Data were analysed by two-way
ANOVA and when statistical significance was achieved a post hoc
Bonferroni test was performed. * P,0.05 significant post hoc effect of
smoke exposure compared to sham animals on the same diet. { P,0.05
significant post hoc effect of HFD compared to chow fed animals.
doi:10.1371/journal.pone.0080471.g004
Figure 5. The effect of subchronic cigarette smoke exposure
and HFD on IGF-I protein level in the gastrocnemius skeletal
muscle. Male BALB/c mice were exposed to 4 cigarettes/day, 6 days/
week for 7 weeks and the protein level of IGF-I in the gastrocnemius
skeletal muscle was determined. Mice had access to either standard
laboratory chow (%) or a HFD (&) across the 7 week experimental
period. Data are shown as mean6SE and each sample was performed in
duplicate (n = 8 per treatment group). Data were analysed by two-way
ANOVA and when statistical significance was achieved a post hoc
Bonferroni test was performed. * P,0.05 significant post hoc effect of
smoke exposure compared to sham animals on the same diet.
doi:10.1371/journal.pone.0080471.g005
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reported both an increase in serum TNF-a and calf skeletal muscle
wasting in C57BL/6 mice after 16 weeks of cigarette smoke
exposure. Moreover, TNF-a receptor 2 deficiency ameliorated the
weight loss and skeletal muscle wasting induced by chronic (18
weeks) cigarette smoke exposure in mice [48]. In the current study,
IL-6 mRNA expression was significantly elevated in all skeletal
muscles of the cigarette smoke exposed mice and this increase was
inhibited by the HFD. The role of local inflammation in skeletal
muscle wasting remains controversial. Local IL-6 expression has
pro- and anti-inflammatory effects and has been implicated in
satellite cell mediated skeletal muscle hypertrophy [49].
In the current study smoke-exposed mice had lower body
weights and skeletal muscle wasting of hind limb muscles prior to
airspace enlargement. While the inhibitory effect of cigarette
smoke on food intake is well established and could account for the
reduction in body weight and skeletal muscle masses we have
shown previously using long-term pair-feeding (1 and 3 months)
that cigarette smoke exposure caused a greater reduction in body
weight compared to equivalent food restriction alone [32,50].
Airspace enlargement was not determined in the current study,
however using a very similar protocol, 8 weeks of smoke exposure
did not induce changes in airspace in BALB/c mice [51], which
typically takes a much longer period of time (6 months) [46] or
nose only exposure [52]. As the reduction in body weight and
skeletal muscle masses occurred prior to airspace enlargement we
suggest that factors(s) in cigarette smoke (reactive oxygen species or
nicotine) and/or a secondary effect (hypoxia or low-grade systemic
inflammation) of the exposure caused a significant component of
the weight loss and skeletal muscle wasting in this model. This was
in line with the observations of reduced body weight prior to
histological changes in the airways of smoke-exposed guinea pigs
and as seen in our study this was in the absence of systemic
inflammation [53]. Oxidative stress is a likely candidate given that
immediately after a single exposure to cigarette smoke there was a
reduction in muscle but not lung glutathione, an important
intracellular antioxidant, and increased lipid peroxidation in the
plasma [53].
Interestingly, we have reported a similar decrease in body
weight and skeletal muscle masses using BALB/c mice seen after
much longer periods (16 or 18 weeks) and higher doses of cigarette
smoke exposure (10 or 20 cigarettes/day) using C57BL/6 mice
[47,48]. Moreover, we (M.J. Hansen, unpublished findings) and
others [46] have shown after 5 and 6 month exposure protocols,
respectively, only a small attenuation of weight gain and no
difference in skeletal muscle weights in smoke-exposed C57BL/6
mice. BALB/c mice were used in the current study as we have
previously found them to be more susceptible than C57BL/6 mice
to the pulmonary inflammatory parameters induced by acute (4
days) cigarette smoke exposure [34]. Thus, it appears that as seen
with the pulmonary inflammation different mouse strains [34,54]
may have varying susceptibilities to the systemic effects (systemic
inflammation, weight loss and skeletal muscle wasting) associated
with cigarette smoke exposure and this will form the basis of future
studies in our laboratory.
While a lower body mass index has been reported to
independently reduce survival of COPD patients [55], in this
study, the greater weight gain of the HFD mice was neither
protective nor detrimental on the body weight and skeletal muscle
masses of cigarette smoke exposed mice. In fact, fat masses were
preserved in the HFD fed animals compared to the chow fed mice
following cigarette smoke exposure and this may result in serious
metabolic health consequences (e.g. insulin insensitivity and
cardiovascular outcomes) in the long term [33].
We found a significant reduction in IGF-1 mRNA expression in
the tibialis anterior and gastrocnemius skeletal muscles of the
smoke-exposed animals. This decrease was reflected in the IGF-1
protein level in the gastrocnemius of chow fed smoke exposed
animals. A significant reduction in IGF mRNA expression in the
quadriceps of COPD patients compared to healthy aged-matched
control subjects has been described [56]. To our knowledge this is
the first time changes in IGF-1 levels have been reported in the
skeletal muscles and plasma of cigarette smoke-exposed mice. As
IGF-1 promotes skeletal muscle hypertrophy by increasing protein
synthesis and satellite cell proliferation and differentiation [26,27],
low IGF-1 may promote skeletal muscle wasting in this model.
Petersen and colleagues reported an increase in atrogin-1 but
not MuRF1 mRNA expression in the skeletal muscle of smokers
compared to never smokers [57]. Similarly, we found that
cigarette smoke exposure alone induced atrogin-1 mRNA but
not MuRF-1 mRNA expression in the gastrocnemius. In contrast,
both E3 ligases were upregulated in the soleus and extensor
digitorum longus after a similar period but higher dose of smoke
exposure in C57BL/6 mice [47]. Interestingly, in our study and
the Petersen study, markers of systemic inflammation (CRP, IL-6,
SAA, TNF-a) were not altered, whereas plasma TNF-a levels were
markedly elevated in the study by Tang and colleagues in C57BL/
6 mice [47]. Thus, systemic inflammation may not be the only
mechanism that contributes to the alterations in atrophy markers
and skeletal muscle mass observed in smokers [57] and mice in our
study. An imbalance in IGF-1 and ubiquitin ligase (atrogin-1)
signaling pathways would have important physiological conse-
quences and in the current study these changes appeared early in
disease progression.
As skeletal muscle wasting is a powerful predictor of mortality in
COPD and is associated with diminished functional status and
quality of life [55], it is important to identify factors that
exacerbate muscle wasting in order to develop therapeutic
interventions. We report for the first time that cigarette smoke
induced a down-regulation in total IGF-1 mRNA expression in the
tibialis anterior and gastrocnemius skeletal muscles of chow and
HFD fed animals. This may contribute to the loss of muscle mass
observed in these mice. Therapeutic interventions that increase
local IGF-1 level in the skeletal muscle of smoke exposed mice may
reverse the muscle loss observed in this model and would avoid the
complications of administering IGF-1 systemically. Good animal
models will not only aid in the identification of atrophy markers
specifically altered by smoke-induced wasting but also allow
pharmacological manipulation and evaluation of these potential
therapeutic targets to determine whether skeletal muscle mass and
function can be improved following prolonged smoke exposure.
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